Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

Concentra® (NYSE: CON), the nation's leader in occupational medicine, today announced that nationally recognized occupational medicine leader Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer, effective Jan. 1, 2027. Returning to the organization where she previously served in physician leadership roles, including area medical director, Dr. Rosenthal will lead Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation as employers increasingly seek integrated workforce health solutions. She succeeds longtime chief medical officer, Dr. John Anderson, who previously announced his retirement effective Dec. 31, 2026, after 33 years with Concentra.